2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
667
Sarcoma
275
Lymphoid
51
Genitourinary
36
Gastrointestinal
36
Gynecologic
29
Dermatologic
23
Other hematologic neoplasm
22
Thoracic
19
Head & Neck
17
Other solid neoplasm
16
Breast
13
Endocrine
12
Myeloid
7
Plasma cell
4
Classical hematology
3
Other
1
NET
1
Conditions
Neuroendocrine Tumors
531
Gastro-enteropancreatic neuroendocrine tumor
58
Carcinoid Tumor
58
Neoplasms
49
Carcinoma, Neuroendocrine
44
Pancreatic Neoplasms
36
Adenoma, Islet Cell
33
Neoplasm Metastasis
28
Pheochromocytoma
25
Colorectal Neoplasms
24
Paraganglioma
23
Stomach Neoplasms
21
Breast Neoplasms
21
Prostatic Neoplasms
20
Lung Neoplasms
20
Carcinoma, Hepatocellular
20
Sarcoma
19
Carcinoma
19
Thyroid Neoplasms
18
Gastrointestinal Neoplasms
18
Neuroblastoma
15
Cholangiocarcinoma
14
Carcinoma, Renal Cell
14
Small Cell Lung Carcinoma
13
Melanoma
13
Esophageal Neoplasms
13
Serotonin Syndrome
12
Colonic Neoplasms
12
Brain Neoplasms
11
Adenocarcinoma
11
Interventions
Quality of Life
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Immunotherapy
1
Drug Therapy
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Astrocytoma
×
NET
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled